Mayo Clinical Cancer Center

Phoenix, Arizona 85054

0 studies enrolling now · 1 studies all time

What they study most

Basal Cell Nevus Syndrome

Studies at this site

• Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome) — Completed